← brief for 2026-09-08 · Slowing decline
Pharmacokinetics of novel drugs for the treatment of Diabetic nephropathy.
Key takeaways
This review covers how the body handles newer drugs for diabetic kidney disease: how much drug gets into the blood, how long it stays, and when the dose needs changing. Damaged kidneys clear drugs more slowly, so a normal dose can build up and cause harm. The authors searched three research databases up to 18 April 2026 and also looked at interactions between drugs. It is a summary of work already published, so there are no new results here.
Who did this work
Mousavi T · Shaya FT · Munir KM · Davis SN
Source
Article · PubMed, the drug frontier · 2026 Sep 8
https://pubmed.ncbi.nlm.nih.gov/42709045/